{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:11:35Z","timestamp":1793329895741,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China Joint Fund for Regional Innovation and Development","award":["U22A203373"],"award-info":[{"award-number":["U22A203373"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic kidney disease (DKD) is widely recognized as a major contributor to end-stage renal disease, in which podocyte injury serves as an important pathological basis for disease progression. ZhiXiaoSanZheng Formula (ZXSZF), an empirically derived traditional Chinese medicine prescription, has shown therapeutic potential in DKD; however, its molecular mechanisms remain unclear. This study investigated whether ZXSZF protects podocytes by modulating ferroptosis-related pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The chemical profile of ZXSZF was analyzed by LC\u2013MS\/MS. Potential bioactive compounds were screened through SwissADME, and putative targets were predicted using SwissTargetPrediction. Overlapping targets among ZXSZF, DKD, and ferroptosis were identified and analyzed through protein\u2013protein interaction and functional enrichment analyses. The predicted mechanisms were further validated in a unilateral nephrectomy plus STZ-induced DKD rat model and in AGEs\u2013stimulated MPC5 podocytes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>LC\u2013MS\/MS analysis identified 94 chemical constituents in ZXSZF. Network pharmacology analysis suggested that antioxidant and ferroptosis-related pathways centered on NRF2 may represent potential regulatory nodes of ZXSZF. In DKD rats, ZXSZF reduced albuminuria and improved renal histopathological changes, accompanied by restoration of podocyte markers and attenuation of ferroptosis-associated alterations. In AGEs-stimulated podocytes, ZXSZF decreased lipid peroxidation and iron accumulation while enhancing cellular antioxidant capacity. These effects were associated with increased NRF2 signaling and upregulation of SLC7A11 and GPX4. Pharmacological inhibition of NRF2 with ML385 partially attenuated the protective effects of ZXSZF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ZXSZF alleviates podocyte injury in DKD and its renoprotective effects are associated with modulation of ferroptosis-related processes involving the NRF2\/SLC7A11\/GPX4 pathway. The present study provides experimental evidence for the mechanistic basis of ZXSZF and supports its potential role as a complementary therapeutic option in DKD management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01389-x","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T08:20:04Z","timestamp":1775550004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["ZhiXiaoSanZheng formula ameliorates podocyte injury in diabetic kidney disease by inhibiting ferroptosis: integrated network pharmacology and experimental validation"],"prefix":"10.1186","volume":"21","author":[{"given":"Shaofeng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaotan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"1389_CR1","doi-asserted-by":"publisher","first-page":"101463","DOI":"10.1016\/j.lanwpc.2024.101463","volume":"55","author":"W Jia","year":"2025","unstructured":"Jia W, Yu R, Wang L, et al. Prevalence of chronic kidney disease among Chinese adults with diabetes: a nationwide population-based cross-sectional study. Lancet Reg Health West Pac. 2025;55:101463. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101463.","journal-title":"Lancet Reg Health West Pac"},{"key":"1389_CR2","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes Atlas, 9th edition. Diabet Res Clin Pract. 2019;157:107843. https:\/\/doi.org\/10.1016\/j.diabres.2019.107843.","journal-title":"Diabet Res Clin Pract"},{"issue":"6","key":"1389_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.123.067584","volume":"149","author":"BL Neuen","year":"2024","unstructured":"Neuen BL, Heerspink HJL, Vart P, et al. Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria. Circulation. 2024;149(6):450\u201362. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067584.","journal-title":"Circulation"},{"issue":"Supplement_1","key":"1389_CR4","doi-asserted-by":"publisher","first-page":"i59","DOI":"10.1093\/ndt\/gfae258","volume":"40","author":"BL Neuen","year":"2025","unstructured":"Neuen BL, Yeung EK, Rangaswami J, Vaduganathan M. Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease. Nephrol Dial Transplant. 2025;40(Supplement_1):i59\u201369. https:\/\/doi.org\/10.1093\/ndt\/gfae258.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1389_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41574-025-01171-3","volume":"22","author":"V Martinez Leon","year":"2026","unstructured":"Martinez Leon V, Hilburg R, Susztak K. Mechanisms of diabetic kidney disease and established and emerging treatments. Nat Rev Endocrinol. 2026;22(1):21\u201335. https:\/\/doi.org\/10.1038\/s41574-025-01171-3.","journal-title":"Nat Rev Endocrinol"},{"key":"1389_CR6","doi-asserted-by":"publisher","first-page":"115670","DOI":"10.1016\/j.biopha.2023.115670","volume":"168","author":"X Li","year":"2023","unstructured":"Li X, Zhang Y, Xing X, et al. Podocyte injury of diabetic nephropathy: novel mechanism discovery and therapeutic prospects. Biomed Pharmacother. 2023;168:115670. https:\/\/doi.org\/10.1016\/j.biopha.2023.115670.","journal-title":"Biomed Pharmacother"},{"key":"1389_CR7","doi-asserted-by":"publisher","first-page":"685447","DOI":"10.3389\/fmed.2021.685447","volume":"8","author":"R Nishad","year":"2021","unstructured":"Nishad R, Tahaseen V, Kavvuri R, et al. Advanced-glycation end-products induce podocyte injury and contribute to proteinuria. Front Med. 2021;8:685447. https:\/\/doi.org\/10.3389\/fmed.2021.685447.","journal-title":"Front Med"},{"issue":"7","key":"1389_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1042\/CS20210625","volume":"136","author":"F Barutta","year":"2022","unstructured":"Barutta F, Bellini S, Gruden G. Mechanisms of podocyte injury and implications for diabetic nephropathy. Clin Sci (Lond). 2022;136(7):493\u2013520. https:\/\/doi.org\/10.1042\/CS20210625.","journal-title":"Clin Sci (Lond)"},{"issue":"9","key":"1389_CR9","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.7150\/ijbs.81892","volume":"19","author":"H Wang","year":"2023","unstructured":"Wang H, Liu D, Zheng B, et al. Emerging role of ferroptosis in diabetic kidney disease: molecular mechanisms and therapeutic opportunities. Int J Biol Sci. 2023;19(9):2678\u201394. https:\/\/doi.org\/10.7150\/ijbs.81892.","journal-title":"Int J Biol Sci"},{"key":"1389_CR10","doi-asserted-by":"publisher","first-page":"117140","DOI":"10.1016\/j.biopha.2024.117140","volume":"177","author":"H Yang","year":"2024","unstructured":"Yang H, Sun J, Sun A, et al. Podocyte programmed cell death in diabetic kidney disease: molecular mechanisms and therapeutic prospects. Biomed Pharmacother. 2024;177:117140. https:\/\/doi.org\/10.1016\/j.biopha.2024.117140.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1389_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382. https:\/\/doi.org\/10.1038\/s41580-020-00324-8.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1389_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2025.02.040","volume":"231","author":"Y Ye","year":"2025","unstructured":"Ye Y, Xie X, Bi Y, et al. Nrf2 alleviates acute ischemic stroke induced ferroptosis via regulating xCT\/GPX4 pathway. Free Radic Biol Med. 2025;231:153\u201362. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.02.040.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1389_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s13063-018-2749-6","volume":"19","author":"M Wang","year":"2018","unstructured":"Wang M, Wang Z, Zhou J, et al. Effects of traditional Chinese herbal medicine in patients with diabetic kidney disease: study protocol for a randomized controlled trial. Trials. 2018;19(1):389. https:\/\/doi.org\/10.1186\/s13063-018-2749-6.","journal-title":"Trials"},{"issue":"4","key":"1389_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.19852\/j.cnki.jtcm.2025.04.017","volume":"45","author":"S Weiwei","year":"2025","unstructured":"Weiwei S, Jiale Z, Hanwen Y, et al. Traditional Chinese herbal medicine Qingre Xiaozheng formula improves renal outcomes in patients with diabetic kidney disease: a retrospective study. J Tradit Chin Med. 2025;45(4):873\u201380. https:\/\/doi.org\/10.19852\/j.cnki.jtcm.2025.04.017.","journal-title":"J Tradit Chin Med"},{"key":"1389_CR15","doi-asserted-by":"publisher","first-page":"112794","DOI":"10.1016\/j.intimp.2024.112794","volume":"141","author":"J Liu","year":"2024","unstructured":"Liu J, Yang K, Zhou L, et al. A new strategy for Astragaloside IV in the treatment of diabetic kidney disease: analyzing the regulation of ferroptosis and mitochondrial function of renal tubular epithelial cells. Int Immunopharmacol. 2024;141:112794. https:\/\/doi.org\/10.1016\/j.intimp.2024.112794.","journal-title":"Int Immunopharmacol"},{"key":"1389_CR16","doi-asserted-by":"publisher","first-page":"155646","DOI":"10.1016\/j.phymed.2024.155646","volume":"129","author":"M Liu","year":"2024","unstructured":"Liu M, Di YM, May B, et al. Renal protective effects and mechanisms of Astragalus membranaceus for diabetic kidney disease in animal models: an updated systematic review and meta-analysis. Phytomedicine. 2024;129:155646. https:\/\/doi.org\/10.1016\/j.phymed.2024.155646.","journal-title":"Phytomedicine"},{"issue":"7","key":"1389_CR17","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.2337\/dc22-0607","volume":"45","author":"J Zhao","year":"2022","unstructured":"Zhao J, Tostivint I, Xu L, et al. Efficacy of combined Abelmoschus manihot and Irbesartan for reduction of albuminuria in patients with type 2 diabetes and diabetic kidney disease: a multicenter randomized double-blind parallel controlled clinical trial. Diabet Care. 2022;45(7):e113\u20135. https:\/\/doi.org\/10.2337\/dc22-0607.","journal-title":"Diabet Care"},{"key":"1389_CR18","doi-asserted-by":"publisher","first-page":"155642","DOI":"10.1016\/j.phymed.2024.155642","volume":"130","author":"C Wu","year":"2024","unstructured":"Wu C, Tang H, Cui X, et al. A single-cell profile reveals the transcriptional regulation responded for Abelmoschus manihot (L.) treatment in diabetic kidney disease. Phytomedicine. 2024;130:155642. https:\/\/doi.org\/10.1016\/j.phymed.2024.155642.","journal-title":"Phytomedicine"},{"issue":"1","key":"1389_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1875-5364(21)60001-8","volume":"19","author":"X Wang","year":"2021","unstructured":"Wang X, Wang ZY, Zheng JH, Li S. TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches. Chin J Nat Med. 2021;19(1):1\u201311. https:\/\/doi.org\/10.1016\/S1875-5364(21)60001-8.","journal-title":"Chin J Nat Med"},{"issue":"1","key":"1389_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13020-024-00991-1","volume":"19","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhao P, Cai Z, et al. Buqi-Huoxue-Tongnao decoction drives gut microbiota-derived indole lactic acid to attenuate ischemic stroke via the gut-brain axis. Chin Med. 2024;19(1):126. https:\/\/doi.org\/10.1186\/s13020-024-00991-1.","journal-title":"Chin Med"},{"key":"1389_CR21","doi-asserted-by":"publisher","first-page":"120157","DOI":"10.1016\/j.jep.2025.120157","volume":"351","author":"J Zhang","year":"2025","unstructured":"Zhang J, Wu Q, Xia C, et al. Qing-Re-Xiao-Zheng-(Yi-Qi) formula attenuates the renal podocyte ferroptosis in diabetic kidney disease through AMPK pathway. J Ethnopharmacol. 2025;351:120157. https:\/\/doi.org\/10.1016\/j.jep.2025.120157.","journal-title":"J Ethnopharmacol"},{"issue":"Pt B","key":"1389_CR22","doi-asserted-by":"publisher","first-page":"120734","DOI":"10.1016\/j.jep.2025.120734","volume":"355","author":"H Chen","year":"2026","unstructured":"Chen H, Li Y, Xia C, et al. Mechanism exploration of QingReXiaoZheng decoction on renoprotection in diabetic kidney disease: integrated network pharmacology, molecular docking and experimental validation. J Ethnopharmacol. 2026;355(Pt B):120734. https:\/\/doi.org\/10.1016\/j.jep.2025.120734.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1389_CR23","doi-asserted-by":"publisher","first-page":"2327495","DOI":"10.1080\/0886022X.2024.2327495","volume":"46","author":"L Zhang","year":"2024","unstructured":"Zhang L, Wang X, Chang L, et al. Quercetin improves diabetic kidney disease by inhibiting ferroptosis and regulating the Nrf2 in streptozotocin-induced diabetic rats. Ren Fail. 2024;46(1):2327495. https:\/\/doi.org\/10.1080\/0886022X.2024.2327495.","journal-title":"Ren Fail"},{"issue":"11","key":"1389_CR24","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/s41419-019-2002-6","volume":"10","author":"WJ Liu","year":"2019","unstructured":"Liu WJ, Gan Y, Huang WF, et al. Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease. Cell Death Dis. 2019;10(11):806. https:\/\/doi.org\/10.1038\/s41419-019-2002-6.","journal-title":"Cell Death Dis"},{"issue":"9","key":"1389_CR25","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1007\/s00125-020-05197-2","volume":"63","author":"M He","year":"2020","unstructured":"He M, Li Y, Wang L, et al. MYDGF attenuates podocyte injury and proteinuria by activating Akt\/BAD signal pathway in mice with diabetic kidney disease. Diabetologia. 2020;63(9):1916\u201331. https:\/\/doi.org\/10.1007\/s00125-020-05197-2.","journal-title":"Diabetologia"},{"key":"1389_CR26","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2147\/DDDT.S509357","volume":"19","author":"M Cui","year":"2025","unstructured":"Cui M, Xu Q, Duan L, Lu J, Hu J. Vaccarin ameliorates renal fibrosis by inhibiting ferroptosis via Nrf2\/SLC7A11\/GPX4 signaling pathway. Drug Des Devel Ther. 2025;19:1609\u201326. https:\/\/doi.org\/10.2147\/DDDT.S509357.","journal-title":"Drug Des Devel Ther"},{"key":"1389_CR27","doi-asserted-by":"publisher","first-page":"992597","DOI":"10.3389\/fphar.2022.992597","volume":"13","author":"Q Wu","year":"2022","unstructured":"Wu Q, Yan R, Yang H, et al. Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease. Front Pharmacol. 2022;13:992597. https:\/\/doi.org\/10.3389\/fphar.2022.992597.","journal-title":"Front Pharmacol"},{"key":"1389_CR28","doi-asserted-by":"publisher","first-page":"119068","DOI":"10.1016\/j.lfs.2021.119068","volume":"269","author":"L Xing","year":"2021","unstructured":"Xing L, Fang J, Zhu B, et al. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPAR\u03b3-Klotho-FoxO1 axis in diabetic nephropathy. Life Sci. 2021;269:119068. https:\/\/doi.org\/10.1016\/j.lfs.2021.119068.","journal-title":"Life Sci"},{"key":"1389_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2023.03.022","volume":"203","author":"Q Shen","year":"2023","unstructured":"Shen Q, Fang J, Guo H, et al. Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE\/TFAM signaling in diabetic kidney disease. Free Radic Biol Med. 2023;203:45\u201357. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.03.022.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1389_CR30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ptr.6818","volume":"35","author":"N Li","year":"2021","unstructured":"Li N, Tang H, Wu L, et al. Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases. Phytother Res. 2021;35(1):198\u2013206. https:\/\/doi.org\/10.1002\/ptr.6818.","journal-title":"Phytother Res"},{"issue":"1","key":"1389_CR31","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1038\/s41467-019-12433-w","volume":"10","author":"Y Zhong","year":"2019","unstructured":"Zhong Y, Lee K, Deng Y, et al. Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes. Nat Commun. 2019;10(1):4523. https:\/\/doi.org\/10.1038\/s41467-019-12433-w.","journal-title":"Nat Commun"},{"issue":"4","key":"1389_CR32","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1142\/S0192415X23500465","volume":"51","author":"Q Feng","year":"2023","unstructured":"Feng Q, Yang Y, Qiao Y, et al. Quercetin ameliorates diabetic kidney injury by inhibiting ferroptosis via activating Nrf2\/HO-1 signaling pathway. Am J Chin Med. 2023;51(4):997\u20131018. https:\/\/doi.org\/10.1142\/S0192415X23500465.","journal-title":"Am J Chin Med"},{"issue":"1","key":"1389_CR33","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1080\/13880209.2022.2067572","volume":"60","author":"D Huang","year":"2022","unstructured":"Huang D, Shen P, Wang C, Gao J, Ye C, Wu F. Calycosin plays a protective role in diabetic kidney disease through the regulation of ferroptosis. Pharm Biol. 2022;60(1):990\u20136. https:\/\/doi.org\/10.1080\/13880209.2022.2067572.","journal-title":"Pharm Biol"},{"key":"1389_CR34","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107. https:\/\/doi.org\/10.1016\/j.redox.2019.101107.","journal-title":"Redox Biol"},{"issue":"6","key":"1389_CR35","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3390\/ph18060887","volume":"18","author":"W Wang","year":"2025","unstructured":"Wang W, Liu Y, Lou W, et al. A comprehensive quality evaluation system for medicinal leeches by integrating macromolecular protein analysis and small-molecule marker detection as well as quantitative bioassays. Pharmaceuticals (Basel). 2025;18(6):887. https:\/\/doi.org\/10.3390\/ph18060887.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"1389_CR36","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.13313\/j.issn.1673-4890.20250115006","volume":"27","author":"CG Wang","year":"2025","unstructured":"Wang CG, Chen H, Deng XQ. Research strategies and application prospects of targets of traditional Chinese medicine prescriptions from a holistic view. Mod Chin Med. 2025;27(10):1805\u201312. https:\/\/doi.org\/10.13313\/j.issn.1673-4890.20250115006.","journal-title":"Mod Chin Med"},{"issue":"07","key":"1389_CR37","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.13313\/j.issn.1673-4890.20241212008","volume":"27","author":"XQ Deng","year":"2025","unstructured":"Deng XQ, Qi RY, Wang CG. Research modes of the functional targets of traditional Chinese medicine prescriptions. Mod Chin Med. 2025;27(07):1197\u2013206. https:\/\/doi.org\/10.13313\/j.issn.1673-4890.20241212008.","journal-title":"Mod Chin Med"},{"issue":"07","key":"1389_CR38","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.13313\/j.issn.1673-4890.20240715006","volume":"27","author":"H Chen","year":"2025","unstructured":"Chen H, Rao QL, Huang ZX, et al. Thermal proteome profiling reveals the targets and potential new efficacy of Notoginseng Radix et Rhizoma decoction in treating encephalopathy. Mod Chin Med. 2025;27(07):1207\u201316. https:\/\/doi.org\/10.13313\/j.issn.1673-4890.20240715006.","journal-title":"Mod Chin Med"},{"issue":"07","key":"1389_CR39","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.13313\/j.issn.1673-4890.20241111003","volume":"27","author":"ZX Huang","year":"2025","unstructured":"Huang ZX, Ma T, Wang CG, et al. Exploration of targets and potential new efficacies of Qinzhi Zhudan decoction in encephalopathy based on thermal proteome profiling. Mod Chin Med. 2025;27(07):1217\u201327. https:\/\/doi.org\/10.13313\/j.issn.1673-4890.20241111003.","journal-title":"Mod Chin Med"},{"key":"1389_CR40","doi-asserted-by":"publisher","first-page":"113350","DOI":"10.1016\/j.jpba.2020.113350","volume":"187","author":"M Ren","year":"2020","unstructured":"Ren M, Xu W, Zhang Y, et al. Qualitative and quantitative analysis of phenolic compounds by UPLC-MS\/MS and biological activities of Pholidota chinensis Lindl. J Pharm Biomed Anal. 2020;187:113350. https:\/\/doi.org\/10.1016\/j.jpba.2020.113350.","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"1389_CR41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/jssc.201401031","volume":"38","author":"Y Chen","year":"2015","unstructured":"Chen Y, Cai S, Deng L, et al. Separation and purification of 9,10-dihydrophenanthrenes and bibenzyls from Pholidota chinensis by high-speed countercurrent chromatography. J Sep Sci. 2015;38(3):453\u20139. https:\/\/doi.org\/10.1002\/jssc.201401031.","journal-title":"J Sep Sci"},{"key":"1389_CR42","doi-asserted-by":"publisher","first-page":"1024239","DOI":"10.3389\/fpls.2022.1024239","volume":"13","author":"B Liu","year":"2022","unstructured":"Liu B, Chen J, Zhang W, et al. The gastrodin biosynthetic pathway in Pholidota chinensis Lindl. revealed by transcriptome and metabolome profiling. Front Plant Sci. 2022;13:1024239. https:\/\/doi.org\/10.3389\/fpls.2022.1024239.","journal-title":"Front Plant Sci"},{"issue":"16","key":"1389_CR43","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1021\/jf2050697","volume":"60","author":"J Liu","year":"2012","unstructured":"Liu J, Cai YZ, Wong RN, et al. Comparative analysis of caffeoylquinic acids and lignans in roots and seeds among various burdock (Arctium lappa) genotypes with high antioxidant activity. J Agric Food Chem. 2012;60(16):4067\u201375. https:\/\/doi.org\/10.1021\/jf2050697.","journal-title":"J Agric Food Chem"},{"issue":"2","key":"1389_CR44","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jpba.2009.03.018","volume":"51","author":"R Ferracane","year":"2010","unstructured":"Ferracane R, Graziani G, Gallo M, Fogliano V, Ritieni A. Metabolic profile of the bioactive compounds of burdock (Arctium lappa) seeds, roots and leaves. J Pharm Biomed Anal. 2010;51(2):399\u2013404. https:\/\/doi.org\/10.1016\/j.jpba.2009.03.018.","journal-title":"J Pharm Biomed Anal"},{"key":"1389_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jchromb.2015.10.021","volume":"1006","author":"LY Du","year":"2015","unstructured":"Du LY, Qian DW, Jiang S, et al. Comparative characterization of nucleotides, nucleosides and nucleobases in Abelmoschus manihot roots, stems, leaves and flowers during different growth periods by UPLC-TQ-MS\/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;1006:130\u20137. https:\/\/doi.org\/10.1016\/j.jchromb.2015.10.021.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1389_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jchromb.2017.05.020","volume":"1059","author":"X Pan","year":"2017","unstructured":"Pan X, Du L, Tao J, Jiang S, Qian D, Duan J. Dynamic changes of flavonoids in Abelmoschus manihot different organs at different growth periods by UPLC-MS\/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1059:21\u20136. https:\/\/doi.org\/10.1016\/j.jchromb.2017.05.020.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"2","key":"1389_CR47","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/metabo13020216","volume":"13","author":"J Hou","year":"2023","unstructured":"Hou J, Zhou Y, Ran L, et al. Transcriptome and metabolome analysis reveal the flavonoid biosynthesis mechanism of Abelmoschus manihot L. at different anthesis stages. Metabolites. 2023;13(2):216. https:\/\/doi.org\/10.3390\/metabo13020216.","journal-title":"Metabolites"},{"issue":"17","key":"1389_CR48","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/jssc.201200231","volume":"35","author":"X Xiao","year":"2012","unstructured":"Xiao X, Si X, Yuan Z, Xu X, Li G. Isolation of fucoxanthin from edible brown algae by microwave-assisted extraction coupled with high-speed countercurrent chromatography. J Sep Sci. 2012;35(17):2313\u20137. https:\/\/doi.org\/10.1002\/jssc.201200231.","journal-title":"J Sep Sci"},{"issue":"4","key":"1389_CR49","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.chmed.2025.08.002","volume":"17","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Ai Y, Zhou J, et al. Unveiling bioactive components in Sargassum fusiforme via phytochemical and biological evaluation: a heterogeneous information ensemble approach. Chin Herb Med. 2025;17(4):822\u201336. https:\/\/doi.org\/10.1016\/j.chmed.2025.08.002.","journal-title":"Chin Herb Med"},{"key":"1389_CR50","doi-asserted-by":"publisher","first-page":"122153","DOI":"10.1016\/j.jchromb.2020.122153","volume":"1151","author":"Q Huang","year":"2020","unstructured":"Huang Q, Gao Q, Chai X, et al. A novel thrombin inhibitory peptide discovered from leech using affinity chromatography combined with ultra-high performance liquid chromatography-high resolution mass spectroscopy. J Chromatogr B Analyt Technol Biomed Life Sci. 2020;1151:122153. https:\/\/doi.org\/10.1016\/j.jchromb.2020.122153.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1389_CR51","doi-asserted-by":"publisher","first-page":"122822","DOI":"10.1016\/j.jchromb.2021.122822","volume":"1178","author":"Q Huang","year":"2021","unstructured":"Huang Q, Tang J, Chai X, et al. Affinity ultrafiltration and UPLC-HR-Orbitrap-MS based screening of thrombin-targeted small molecules with anticoagulation activity from Poecilobdella manillensis. J Chromatogr B Analyt Technol Biomed Life Sci. 2021;1178:122822. https:\/\/doi.org\/10.1016\/j.jchromb.2021.122822.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"11","key":"1389_CR52","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/antiox10111852","volume":"10","author":"Z Sheng","year":"2021","unstructured":"Sheng Z, Jiang Y, Liu J, Yang B. UHPLC-MS\/MS analysis on flavonoids composition in Astragalus membranaceus and their antioxidant activity. Antioxidants. 2021;10(11):1852. https:\/\/doi.org\/10.3390\/antiox10111852.","journal-title":"Antioxidants"},{"issue":"22","key":"1389_CR53","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.3390\/molecules24224064","volume":"24","author":"Y Wang","year":"2019","unstructured":"Wang Y, Liu L, Ma Y, et al. Chemical discrimination of Astragalus mongholicus and Astragalus membranaceus based on metabolomics using UHPLC-ESI-Q-TOF-MS\/MS approach. Molecules. 2019;24(22):4064. https:\/\/doi.org\/10.3390\/molecules24224064.","journal-title":"Molecules"},{"issue":"3","key":"1389_CR54","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.chmed.2021.06.007","volume":"14","author":"D Li","year":"2022","unstructured":"Li D, Liu Y, Qin X. Rapid quantitative analysis of 12 chemical constituents in wild-simulated and cultivated Astragali Radix based on UHPLC-MS. Chin Herb Med. 2022;14(3):464\u20139. https:\/\/doi.org\/10.1016\/j.chmed.2021.06.007.","journal-title":"Chin Herb Med"},{"key":"1389_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.chroma.2018.04.036","volume":"1554","author":"M He","year":"2018","unstructured":"He M, Jia J, Li J, et al. Application of characteristic ion filtering with ultra-high performance liquid chromatography quadrupole time of flight tandem mass spectrometry for rapid detection and identification of chemical profiling in Eucommia ulmoides Oliv. J Chromatogr A. 2018;1554:81\u201391. https:\/\/doi.org\/10.1016\/j.chroma.2018.04.036.","journal-title":"J Chromatogr A"},{"key":"1389_CR56","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jpba.2011.08.023","volume":"57","author":"X Chai","year":"2012","unstructured":"Chai X, Wang Y, Su Y, et al. A rapid ultra performance liquid chromatography-tandem mass spectrometric method for the qualitative and quantitative analysis of ten compounds in Eucommia ulmodies Oliv. J Pharm Biomed Anal. 2012;57:52\u201361. https:\/\/doi.org\/10.1016\/j.jpba.2011.08.023.","journal-title":"J Pharm Biomed Anal"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01389-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01389-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01389-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:03:44Z","timestamp":1780286624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01389-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1389"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01389-x","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The co-first author symbol for the third author has been fixed.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Animal Experiment Ethics Committee of Beijing University of Chinese Medicine (No. BUCM-2022111002\u20134084) and performed in accordance with relevant institutional guidelines. The study did not involve human participants, human data, or human tissue.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}